Literature DB >> 21445033

Assessment of motor balance and coordination in mice using the balance beam.

Tinh N Luong1, Holly J Carlisle, Amber Southwell, Paul H Patterson.   

Abstract

Brain injury, genetic manipulations, and pharmacological treatments can result in alterations of motor skills in mice. Fine motor coordination and balance can be assessed by the beam walking assay. The goal of this test is for the mouse to stay upright and walk across an elevated narrow beam to a safe platform. This test takes place over 3 consecutive days: 2 days of training and 1 day of testing. Performance on the beam is quantified by measuring the time it takes for the mouse to traverse the beam and the number of paw slips that occur in the process. Here we report the protocol used in our laboratory, and representative results from a cohort of C57BL/6 mice. This task is particularly useful for detecting subtle deficits in motor skills and balance that may not be detected by other motor tests, such as the Rotarod.

Entities:  

Mesh:

Year:  2011        PMID: 21445033      PMCID: PMC3197288          DOI: 10.3791/2376

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  9 in total

1.  Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.

Authors:  R J Carter; L A Lione; T Humby; L Mangiarini; A Mahal; G P Bates; S B Dunnett; A J Morton
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

2.  The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines.

Authors:  Joanna L Stanley; Rachael J Lincoln; Terry A Brown; Louise M McDonald; Gerard R Dawson; David S Reynolds
Journal:  J Psychopharmacol       Date:  2005-05       Impact factor: 4.153

3.  Sustained sensory/motor and cognitive deficits with neuronal apoptosis following controlled cortical impact brain injury in the mouse.

Authors:  G B Fox; L Fan; R A Levasseur; A I Faden
Journal:  J Neurotrauma       Date:  1998-08       Impact factor: 5.269

Review 4.  Tests to assess motor phenotype in mice: a user's guide.

Authors:  Simon P Brooks; Stephen B Dunnett
Journal:  Nat Rev Neurosci       Date:  2009-06-10       Impact factor: 34.870

5.  Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease.

Authors:  Amber L Southwell; Jan Ko; Paul H Patterson
Journal:  J Neurosci       Date:  2009-10-28       Impact factor: 6.167

6.  Motor coordination and balance in rodents.

Authors:  R J Carter; J Morton; S B Dunnett
Journal:  Curr Protoc Neurosci       Date:  2001-08

7.  Early deficits in motor coordination and cognitive dysfunction in a mouse model of the neurodegenerative lysosomal storage disorder, Sandhoff disease.

Authors:  Maria Gulinello; Fengying Chen; Kostantin Dobrenis
Journal:  Behav Brain Res       Date:  2008-06-20       Impact factor: 3.332

8.  Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury.

Authors:  D M Feeney; A Gonzalez; W A Law
Journal:  Science       Date:  1982-08-27       Impact factor: 47.728

9.  Motor and reflexive behavior in the aging rat.

Authors:  J E Wallace; E E Krauter; B A Campbell
Journal:  J Gerontol       Date:  1980-05
  9 in total
  106 in total

1.  Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.

Authors:  Sara Ornaghi; Lawrence S Hsieh; Angélique Bordey; Patrizia Vergani; Michael J Paidas; Anthony N van den Pol
Journal:  J Neurosci       Date:  2017-06-19       Impact factor: 6.167

2.  A combination antioxidant therapy to inhibit NOX2 and activate Nrf2 decreases secondary brain damage and improves functional recovery after traumatic brain injury.

Authors:  Raghavendar Chandran; TaeHee Kim; Suresh L Mehta; Eshwar Udho; Vishal Chanana; Pelin Cengiz; HwuiWon Kim; Chanul Kim; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2017-10-30       Impact factor: 6.200

3.  Therapeutic Hypothermia Provides Variable Protection against Behavioral Deficits after Neonatal Hypoxia-Ischemia: A Potential Role for Brain-Derived Neurotrophic Factor.

Authors:  Johana Diaz; Suleiman Abiola; Nancy Kim; Oliver Avaritt; Debra Flock; Jenny Yu; Frances J Northington; Raul Chavez-Valdez
Journal:  Dev Neurosci       Date:  2017-02-15       Impact factor: 2.984

4.  Treating SCA1 Mice with Water-Soluble Compounds to Non-Specifically Boost Mitochondrial Function.

Authors:  Austin Ferro; Emily Carbone; Evan Marzouk; Asher Siegel; Donna Nguyen; Kailen Polley; Jessilyn Hartman; Kimberley Frederick; Stephen Ives; Sarita Lagalwar
Journal:  J Vis Exp       Date:  2017-01-22       Impact factor: 1.355

5.  Sacs knockout mice present pathophysiological defects underlying autosomal recessive spastic ataxia of Charlevoix-Saguenay.

Authors:  Roxanne Larivière; Rébecca Gaudet; Benoit J Gentil; Martine Girard; Talita Cristiane Conte; Sandra Minotti; Kim Leclerc-Desaulniers; Kalle Gehring; R Anne McKinney; Eric A Shoubridge; Peter S McPherson; Heather D Durham; Bernard Brais
Journal:  Hum Mol Genet       Date:  2014-09-26       Impact factor: 6.150

6.  Tiagabine treatment in kainic acid induced cerebellar lesion of dystonia rat model.

Authors:  Tsui-Chin Wang; Sukonthar Ngampramuan; Naiphinich Kotchabhakdi
Journal:  EXCLI J       Date:  2016-11-17       Impact factor: 4.068

7.  ERBB3-mediated regulation of Bergmann glia proliferation in cerebellar lamination.

Authors:  Anupama Sathyamurthy; Dong-Min Yin; Arnab Barik; Chengyong Shen; Jonathan C Bean; Dwight Figueiredo; Jin-Xiong She; Wen-Cheng Xiong; Lin Mei
Journal:  Development       Date:  2015-01-06       Impact factor: 6.868

8.  Skilled Movements in Mice Require Inhibition of Corticospinal Axon Collateral Formation in the Spinal Cord by Semaphorin Signaling.

Authors:  Zirong Gu; Masaki Ueno; Kelsey Klinefelter; Madhulika Mamidi; Takeshi Yagi; Yutaka Yoshida
Journal:  J Neurosci       Date:  2019-09-19       Impact factor: 6.167

9.  Genes to treat excitotoxicity ameliorate the symptoms of the disease in mice models of multiple system atrophy.

Authors:  Micaela Johanna Glat; Nadia Stefanova; Gregor Karl Wenning; Daniel Offen
Journal:  J Neural Transm (Vienna)       Date:  2020-02-17       Impact factor: 3.575

10.  The microglial α7-acetylcholine nicotinic receptor is a key element in promoting neuroprotection by inducing heme oxygenase-1 via nuclear factor erythroid-2-related factor 2.

Authors:  Esther Parada; Javier Egea; Izaskun Buendia; Pilar Negredo; Ana C Cunha; Silvia Cardoso; Miguel P Soares; Manuela G López
Journal:  Antioxid Redox Signal       Date:  2013-02-25       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.